Page 32 - COVID-19-Mortality-review-in-Malaysia-and-updates-on-clinical-management-of-COVID-19
P. 32
Remdesivir for the treatment of COVID-19: baseline
characteristics
The most recent studies looked at Remdesivir for treatment of COVID-19 done in the
US [7]. These are the baseline characteristics of patients in diagram 15. Majority of the
patients were given Remdesivir. It is for
● hospitalized patients who were receiving supplemental oxygen,
● hospitalized patients who were not in supplemental oxygen,
● hospitalized patients who were not on invasive ventilation and
● hospitalized patients who were on invasive mechanical ventilation.
These are the 4 groups of patients, and they had about 1000 patients: 541 patients
on Remdesivir and 522 patients on placebo.
Diagram 14: Baseline characteristics in the Remdesivir for the treatment of COVID-
19 by Beigel et al.
